2017
DOI: 10.14309/00000434-201710001-00420
|View full text |Cite
|
Sign up to set email alerts
|

A Comparison of the Efficacy and Safety of 2 Dosing Regimens, 2 and 5 Times per Week, of an Intraluminal Vibrating Capsule in the Management of Chronic Idiopathic Constipation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Two dosing regimens of the vibrating capsule were also compared via an aggregation of data from two studies, with inclusion criteria being subjects with CIC who also satisfied Rome III criteria for constipation, and both groups exhibiting comparable exclusion and inclusion criteria [20]. In the first study 163 subjects ingested two capsules each week for eight weeks at the site, meanwhile, in the second study, 25 subjects ingested five capsules each week for eight weeks at home.…”
Section: Table 1: Results Of Sample Studies and Clinical Implicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Two dosing regimens of the vibrating capsule were also compared via an aggregation of data from two studies, with inclusion criteria being subjects with CIC who also satisfied Rome III criteria for constipation, and both groups exhibiting comparable exclusion and inclusion criteria [20]. In the first study 163 subjects ingested two capsules each week for eight weeks at the site, meanwhile, in the second study, 25 subjects ingested five capsules each week for eight weeks at home.…”
Section: Table 1: Results Of Sample Studies and Clinical Implicationsmentioning
confidence: 99%
“…In articles that were included in the review, some of the details that were extracted included the study methodology, details of interventions and controls, and study population and demographics. The following Figure 1 is a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram that offers a research summary of the article selection criteria [14][15][16][17][18][19][20][21][22][23].…”
Section: Review Materials and Methodsmentioning
confidence: 99%